Overexpression of alpha-defensin is associated with bladder cancer invasiveness

Urologic Oncology
Daniel A HoltermanAntonia Vlahou

Abstract

Alpha-defensin (alpha-defensin) has been identified as a potential marker for bladder cancer in urine by surface enhanced laser desorption ionization studies, and confirmed using both immunoabsorption and immunodepletion studies. The objective of this study was to investigate the role of alpha-defensin in bladder cancer. Immunohistochemical analysis of tissue sections showed that alpha-defensin peptides are frequently expressed in bladder cancer cells. It is noteworthy that expression of alpha-defensins increased with tumor invasiveness. Surface enhanced laser desorption ionization analysis showed the presence of alpha-defensin in the T24 and A498 cancer cell lines. These cell lines show higher classically aggressive in vitro characteristics compared with the J82 cells that did not express alpha-defensin. Exogenously added alpha-defensin increased the proliferation and motility/invasiveness of these cell lines using respective assays. It is interesting that alpha-defensin peptides increased intracellular calcium ions (Ca2+). These data are consistent with a role for alpha-defensin in bladder cancer via modulation of cell motility and invasiveness using common intracellular signals, such as Ca2+. We propose that autocrine tumor ...Continue Reading

References

May 1, 1973·International Journal of Cancer. Journal International Du Cancer·J BubeníkJ Donner
Mar 1, 1994·Cancer Metastasis Reviews·K Cole, E Kohn
May 1, 1993·Journal of Cellular Physiology·C J MurphyT W Reid
Feb 23, 1996·The Journal of Biological Chemistry·E B MallowC L Bevins
Dec 1, 1995·The Journal of Clinical Investigation·W B BachinskyM A Golden
Jan 1, 1997·Current Opinion in Hematology·T Ganz, R I Lehrer
Dec 10, 1999·The Journal of Allergy and Clinical Immunology·S van WeteringP S Hiemstra
Apr 4, 2003·Cancer·Sana Al-Sukhun, Maha Hussain
Feb 11, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Min WanJesper Z Haeggström

❮ Previous
Next ❯

Citations

Oct 28, 2008·BMC Medical Genomics·Oi Lian KonM Priyanthi Kumarasinghe
Aug 23, 2011·PloS One·Ji-Lin WangJing-Yuan Fang
Mar 13, 2013·Molecular Diagnosis & Therapy·Steve GoodisonVirginia Urquidi
Aug 21, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ana Navas-Acien, Eliseo Guallar
Jan 12, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Mohamed Zaiou
Jan 5, 2008·World Journal of Urology·Eric SchifferAntonia Vlahou
Jun 11, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Galina S ZamayAnna S Zamay
Aug 11, 2012·PloS One·Tadeusz MajewskiBogdan Czerniak
Dec 3, 2014·Biochimica Et Biophysica Acta·Diana GasparMiguel A R B Castanho
Mar 23, 2017·Molecular Therapy. Nucleic Acids·Galina S ZamayAnna S Zamay
Dec 17, 2011·International Journal of Molecular Sciences·Sammy Al-BennaLars Steinstraesser
May 19, 2011·Proteomics. Clinical Applications·Petra ZürbigAntonia Vlahou
Aug 1, 2007·Proteomics. Clinical Applications·Richard R DrakeO John Semmes
Oct 9, 2009·Expert Review of Proteomics·Steve GoodisonVirginia Urquidi
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Soudeh Ghafouri-FardElahe Motevaseli
Nov 16, 2017·Cancers·Tatiana N ZamayAnna S Kichkailo
May 28, 2020·Frontiers in Immunology·Dan Xu, Wuyuan Lu
Aug 1, 2020·Frontiers in Immunology·Els LebeggeJo A Van Ginderachter
Jan 14, 2021·Cancer Metastasis Reviews·Kavita RawatAnju Shrivastava
Feb 3, 2009·Journal of Proteomics·Nathalie DroinEric Solary

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jakob AlbrethsenSteen Gammeltoft
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Hongzhi ZouDavid A Ahlquist
© 2021 Meta ULC. All rights reserved